ReviewDrugs in context2020

Pharmaceutical, clinical, and resistance information on doravirine, a novel non-nucleoside reverse transcriptase inhibitor for the treatment of HIV-1 infection.

Hanh Thi Pham et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.